MONTREAL, March 9 /PRNewswire-FirstCall/ - www.monacorporation.com - The Company -- (Pink Sheets:MONA - News) MONA Operating subsidiary ITI BioTech today announced that it will seek approval from the FDA, Health Canada, as well as ECO Logo, which is the international standard, for its X10 product. "We are proud to announce that our revolutionary product, the X10, which has proven in all laboratory and clinical tests to be the only defense against many airborne viruses, and can effectively eradicate the growth and contamination of mold and mildew, will seek FDA and Health Canada approval, and we will simultaneously submit for approval to Eco-Logo which is the new worldwide standard for biological products. We are completely confident that all will proceed quickly and will give us a worldwide market to sell our products to," stated Paul Sylvestre, President of I.T.I. Bio-Tech.
About I.T.I. Bio-Tech
ITI is a Bio-Tech company, specializing in the manufacturing of products Eliminating Airborne VOC'S. Products manufactured by ITI are laboratory tested, laboratory certified, biodegradable, food grade approved chemicals, natural scents. Using recyclable containers, perforated caps to ensure safety of children and pets and environmentally safe for the well-being of the people and planet.
Disclaimer:
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking statements", which are related to future, not past, events. Any such forward-looking statements are not assurances of future performance and involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. These risks and uncertainties include, among other things,(a) general economic and (b) our cost of financing, (c) our ability to complete acquisitions and dispositions and the risks associated therewith, and (d) our ability to retain key personnel. These factors, as well as additional factors, could affect our forward-looking statements. We urge you to carefully consider this information. We undertake no duty to update our forward-looking statements, including our earnings outlook.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment